Quick Links

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Lilly.

For further information concerning Lilly grant funding, visit

Community Practice Connections™: Oncology Best Practice™ Optimizing Outcomes When Quality Is Being Measured: A Focus on Evidence-Based Care for Gastric and Gastroesophageal Junction Cancer Treatment

Release Date: June 15, 2017
Expiration Date: June 15, 2018
Media: Internet - based


Activity Overview

In patients with advanced gastric and gastroesophageal junction (GEJ) cancers, clinicians need to use patient and tumor characteristics to choose appropriate evidence-based treatment approaches across multiple lines of therapy. Knowledge of key trials and clinical data should inform clinical decision making and allow for optimized treatment sequencing and proactive mitigation of predictable treatment-related toxicities for patients with these difficult-to-treat solid tumors.

Accordingly, there is a need for educational activities targeted to community practitioners that illustrate how to consider and apply key data sets in the context of the real-world scenarios these clinicians routinely encounter in their practice settings. To meet these educational needs, this online activity interviewed 2 experts who have provided an overview of the treatment landscape for advanced gastric cancers and synthesized data sets on newly available and late-stage investigational strategies to assist community practitioners in optimizing outcomes for their patients.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Lilly.

For further information concerning Lilly grant funding, visit

Instructions for This Activity and Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video files” will be available for your reference.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This activity is directed toward community oncologists who treat or manage patients with gastric or GEJ cancers. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment or management of these tumors are also invited to participate.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:

  • Discuss current evidence-based recommendations and quality measures for the management of locally advanced and metastatic gastric and GEJ cancers
  • Evaluate the efficacy and safety profiles of current and emerging therapies for locally advanced and metastatic gastric and GEJ cancers
  • Individualize treatment by optimizing treatment sequencing and the management of treatment-related adverse events for locally advanced or metastatic gastric and GEJ cancers
  • Apply clinical trial data for first- and second-line therapies for locally advanced or metastatic gastric and GEJ cancers

Faculty, Staff, and Planners' Disclosures


Tanios Bekaii-Saab, MD, FACP
Professor, Mayo Clinic College of Medicine and Science
Co-Leader, GI Cancer Program, Mayo Clinic Cancer Center
Senior Associate Consultant, Mayo Clinic
Scottsdale, AZ

Disclosure: Consultant: Genentech, Amgen, Celgene, Merrimack, Glenmark, Bayer; Other: Exelixis, ARMO, Merck, and SillaJen (Data and Safety Monitoring Board)

Manish A. Shah, MD
Bartlett Family Associate Professor of Gastrointestinal Oncology
Co-Director, Center for Advanced Digestive Care
Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine
Weill Cornell Medical College/New York-Presbyterian Hospital
New York, NY

Disclosure: Grant/Research Support: Roche, Boston Biomedical, Lilly

The staff of PER® have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

CME/CE Provider Contact Information

Physicians’ Education Resource®, LLC
2 Clarke Drive
Suite 110
Cranbury, NJ 08512

Hardware And Software Requirements 

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)

  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Minimum System Requirements (Mac OS)

  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Become a Member

Forgot Password?
Calendar of Events
Filter By